CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464348039
- Phone
- 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-08 | Cormorant Asset Management, LP 10% owner | Purchase | +156,597 | $45.26 | $7.1M | 2,016,138 |
| 2024-03-08 | Cormorant Asset Management, LP 10% owner | Purchase | +8,862 | $45.96 | $407K | 2,025,000 |
| 2024-03-07 | Cormorant Asset Management, LP 10% owner | Purchase | +46,799 | $37.82 | $1.8M | 1,521,799 |
| 2024-03-07 | Cormorant Asset Management, LP 10% owner | Purchase | +10,736 | $39.13 | $420K | 1,532,535 |
| 2024-03-07 | Cormorant Asset Management, LP 10% owner | Purchase | +90,325 | $39.99 | $3.6M | 1,622,860 |
| 2024-03-07 | Cormorant Asset Management, LP 10% owner | Purchase | +102,140 | $41.23 | $4.2M | 1,725,000 |
| 2024-02-27 | Smethurst Dominic Chief Medical Officer | Grant or award | +50,000 | 50,000 | ||
| 2024-02-27 | Smethurst Dominic Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-02-12 | Moran Sean F. Chief Financial Officer | Grant or award | +40,176 | 46,818 | ||
| 2024-02-12 | Moran Sean F. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +40,176 | 40,176 | ||
| 2024-02-12 | Cohen Yuval Chief Executive Officer | Grant or award | +73,947 | 84,400 | ||
| 2024-02-12 | Cohen Yuval Chief Executive Officer | Grant or award · Stock Option (right to buy) | +73,947 | 73,947 | ||
| 2024-02-02 | Cormorant Asset Management, LP 10% owner | Purchase | +750,000 | $19.00 | $14.3M | 1,475,000 |
| 2024-01-26 | HOLMER ALAN F Director | Option exercise | +629 | $4.97 | $3K | 1,379 |
| 2024-01-26 | HOLMER ALAN F Director | Option exercise · Options to purchase common stock | −629 | $4.97 | $3K | 0 |
| 2024-01-26 | Cohen Yuval Chief Executive Officer | Option exercise | +7,179 | $4.97 | $36K | 7,179 |
| 2024-01-26 | Cohen Yuval Chief Executive Officer | Option exercise · Options to purchase common stock | −7,179 | $4.97 | $36K | 0 |
| 2024-01-26 | Cormorant Asset Management, LP 10% owner | Purchase | +14,388 | $25.73 | $370K | 456,756 |
| 2024-01-26 | Cormorant Asset Management, LP 10% owner | Purchase | +15,243 | $26.66 | $406K | 471,999 |
| 2024-01-26 | Cormorant Asset Management, LP 10% owner | Purchase | +36,747 | $27.70 | $1.0M | 508,746 |
Page 8 of 10 · 200 trades